美股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

YD Bio Ltd

13.89

+1.3911.14%

成交量：22.67万

成交额：316.97万

市值：9.77亿

市盈率：-11.23

高：14.75

开：12.69

低：12.51

收：12.50

52周最高：31.00

52周最低：5.30

股本：7,031.98万

流通股本：1,326.54万

量比：1.77

换手率：1.71%

股息：- -

股息率：- -

每股收益(TTM):-1.2365

每股收益(LYR):-0.5757

净资产收益率：--

总资产收益率：--

市净率：--

市盈率(LYR):-24.13

数据加载中...

总览公司新闻公告

公司资料

公司名字：

YD Bio Ltd

交易所：

NASDAQ

成立时间：

- -

员工人数：

- -

公司地址：

12th Floor, No. 101,Section 2,Nanjing East Road,Zhongshan District,Taipei,Taiwan

官网：

- -

邮编：

54186159

电话：

- -

传真：

- -

简介：

YD Bio Limited于2024年2月6日在开曼群岛注册成立。他们是一家生物制药公司，专注于基于血液的癌症检测，开发基于干细胞和外泌体的疗法，具有转变治疗具有高度未满足医疗需求的广谱疾病的潜力，并作为制药公司值得信赖的临床检验药物供应商。他们的商业模式集中于与生物制药公司发展合作伙伴关系，将创新技术转化为商业上可行的药物和癌症检测。

董事

名称

职位

J. Douglas Ramsey

Chairman of the Board, Chief Executive Officer and Chief Financial Officer

Albert McLelland

Independent Director

Bill Stark

Independent Director

James L. Williams

Independent Director

Robert Lee Thomas

Independent Director

Russell D. Griffin

President and Director

股东

名称

职位

J. Douglas Ramsey

Chairman of the Board, Chief Executive Officer and Chief Financial Officer

Charles C. Ross

Chief Operating Officer

Russell D. Griffin

President and Director

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/YDES/company"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"YDES","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"YDES\",,,,,undefined,":{"symbol":"YDES","market":"US","secType":"STK","nameCN":"YD Bio Ltd","latestPrice":13.8922,"timestamp":1756835773390,"preClose":12.5,"halted":0,"volume":226672,"delay":0,"floatShares":13265400,"shares":70319824,"eps":-1.236523,"marketStatus":"交易中","change":1.3922,"latestTime":"09-02 13:56:35 EDT","open":12.69,"high":14.75,"low":12.5101,"amount":3169679.698944,"amplitude":0.179192,"askPrice":14.08,"askSize":3,"bidPrice":13.81,"bidSize":199,"shortable":3,"etf":0,"ttmEps":-1.236523,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1756843200000},"marketStatusCode":2,"adr":0,"listingDate":1756440000000,"exchange":"NASDAQ","adjPreClose":12.5,"preHourTrading":{"tag":"盘前","latestPrice":12.74,"preClose":12.5,"latestTime":"09:27 EDT","volume":27474,"amount":348863.807988,"timestamp":1756819645733},"postHourTrading":{"tag":"盘后","latestPrice":12.5,"preClose":12.5,"latestTime":"19:59 EDT","volume":23864,"amount":285093.639,"timestamp":1756511985963},"volumeRatio":1.773289},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"YDES\",,,,,undefined,":{"symbol":"YDES","floatShares":13265400,"roa":"--","roe":"--","lyrEps":-0.575707,"volumeRatio":1.773289,"shares":70319824,"dividePrice":0,"high":14.75,"amplitude":0.179192,"preClose":12.5,"low":12.5101,"week52Low":5.3,"pbRate":"--","week52High":31,"institutionHeld":0,"latestPrice":13.8922,"committee":0.970297,"eps":-1.236523,"divideRate":0,"volume":226672,"delay":0,"ttmEps":-1.236523,"open":12.69,"prevYearClose":11.25,"prevWeekClose":12.5,"prevMonthClose":12.5,"prevQuarterClose":12.69,"fiveDayClose":11.8,"twentyDayClose":12.03,"sixtyDayClose":11.85},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/YDES\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-08-19","symbol":"YDES","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盘后","type":"earning","dateTimestamp":1755576000000,"reportTimeType":"post","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"YDES\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"YDES\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":1898493574,"address":"12th Floor, No. 101,Section 2,Nanjing East Road,Zhongshan District,Taipei,Taiwan","zipCode":"54186159"},"stockCompanyDetail":{"stockEarnings":[{"period":"1week","weight":0.0417},{"period":"1month","weight":0.0391},{"period":"3month","weight":0.0557},{"period":"6month","weight":0.1455},{"period":"1year","weight":0.1091},{"period":"ytd","weight":0.1111}],"compareEarnings":[{"period":"1week","weight":-0.0004},{"period":"1month","weight":0.0167},{"period":"3month","weight":0.0944},{"period":"6month","weight":0.0856},{"period":"1year","weight":0.1553},{"period":"ytd","weight":0.1006}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"YD Bio Limited于2024年2月6日在开曼群岛注册成立。他们是一家生物制药公司，专注于基于血液的癌症检测，开发基于干细胞和外泌体的疗法，具有转变治疗具有高度未满足医疗需求的广谱疾病的潜力，并作为制药公司值得信赖的临床检验药物供应商。他们的商业模式集中于与生物制药公司发展合作伙伴关系，将创新技术转化为商业上可行的药物和癌症检测。","exchange":"NASDAQ","name":"YD Bio Ltd","nameEN":"YD Bio Ltd"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"YDES\",market:\"US\",,,undefined,":{"directors":[{"name":"J. Douglas Ramsey","position":"Chairman of the Board, Chief Executive Officer and Chief Financial Officer"},{"name":"Albert McLelland","position":"Independent Director"},{"name":"Bill Stark","position":"Independent Director"},{"name":"James L. Williams","position":"Independent Director"},{"name":"Robert Lee Thomas","position":"Independent Director"},{"name":"Russell D. Griffin","position":"President and Director"}],"executives":[{"name":"J. Douglas Ramsey","position":"Chairman of the Board, Chief Executive Officer and Chief Financial Officer"},{"name":"Charles C. Ross","position":"Chief Operating Officer"},{"name":"Russell D. Griffin","position":"President and Director"}]}}}